# KETAMINE FOR METHAMPHETAMINE USE DISORDER STUDY (CTN-0132). 09/28/2022 - 08/21/2025. DSC6. 75N95022F00004 (TO4).

> **NIH NIH N01** · THE EMMES COMPANY, LLC · 2022 · $1,399,972

## Abstract

Substance Misuse

## Key facts

- **NIH application ID:** 10720987
- **Project number:** 75N95022D00017-0-759502200004-1
- **Recipient organization:** THE EMMES COMPANY, LLC
- **Principal Investigator:** JENNIFER MCCORMACK
- **Activity code:** N01 (R01, R21, SBIR, etc.)
- **Funding institute:** NIH
- **Fiscal year:** 2022
- **Award amount:** $1,399,972
- **Award type:** —
- **Project period:** 2022-09-28 → 2025-08-21

## Primary source

NIH RePORTER: https://reporter.nih.gov/project-details/10720987

## Citation

> US National Institutes of Health, RePORTER application 10720987, KETAMINE FOR METHAMPHETAMINE USE DISORDER STUDY (CTN-0132). 09/28/2022 - 08/21/2025. DSC6. 75N95022F00004 (TO4). (75N95022D00017-0-759502200004-1). Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/grant/nih/10720987. Licensed CC0.

---

*[NIH grants dataset](/datasets/nih-grants) · CC0 1.0*